ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,352.00
-0.04%
US Tech 100
18,526.80
-0.08%
Dow Jones
38,878.30
0.18%
Brent Oil
79.795
1.57%
Bitcoin
70,555.73
-0.73%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/06/20243:54PMBusiness WireRémy Cointreau: Information on the Total Number of Voting Rights and Shares Forming the Share Capital on the Date of Publication of the Meeting Notice of the Combined General Meeting of July 20, 2023EU:RCORemy Cointreau SA
06/06/20243:53PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
06/06/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCARPACCAR Inc
06/06/20243:53PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
06/06/20243:52PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RENBRenovaro Inc
06/06/20243:52PMGlobeNewswire Inc.Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2NASDAQ:TVGNWTevogen Bio Holdings Inc
06/06/20243:52PMGlobeNewswire Inc.Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2NASDAQ:TVGNTevogen Bio Holdings Inc
06/06/20243:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCARPACCAR Inc
06/06/20243:52PMPR Newswire (US)Bill Nye headlines the Annual Ad Astra Technology Summit in 2024
06/06/20243:51PMAlliance NewsAlliance NewsDutch exit poll: Green/left group edges out Wilders in EU vote
06/06/20243:51PMEdgar (US Regulatory)Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend]USOTC:WDLFDecentral Life Inc (PK)
06/06/20243:51PMPR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - LABZ
06/06/20243:50PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:SSYSunlink Health Systems
06/06/20243:50PMAlliance NewsAlliance NewsHamas says President Biden's Gaza ceasefire plan 'just words'
06/06/20243:50PMGlobeNewswire Inc.New legal complaint filed against Cascadia Liquor at the BC Labour Relations Board by SEIU Local 2
06/06/20243:50PMGlobeNewswire Inc.Direct Energy Regulated Services Announces Electric Rates for June 2024
06/06/20243:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROLRollins Inc
06/06/20243:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCARPACCAR Inc
06/06/20243:50PMBusiness Wireモトローラ、ラディン語の追加により先住民言語のサポートを拡大
06/06/20243:49PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
06/06/20243:49PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
06/06/20243:49PMBusiness WireExscientia nomme de nouveaux dirigeants pour accentuer l'impact des technologies intégrées et recentrer l'expertise en développement clinique sur l'oncologieNASDAQ:EXAIExscientia PLC
06/06/20243:49PMBusiness WireInverness Graham Announces Majority Recapitalization of My Yield
06/06/20243:47PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
06/06/20243:47PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
06/06/20243:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STBAS and T Bancorp Inc
06/06/20243:45PMPR Newswire (US)OceanShot Coral Reef Restoration Project Announces Expansion and Innovation Learning Lab During World Oceans Week
06/06/20243:44PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
06/06/20243:44PMBusiness WireMotorola erweitert die Unterstützung indigener Sprachen um Ladinisch
06/06/20243:44PMPR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - LABZ

Your Recent History

USOTC
HMLA
Himalaya Technologies (PK)
NYSE
GME
GameStop
USOTC
AAPJ
AAP (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
GDVM
Global Developments (PK)
NASDAQ
NVDA
NVIDIA
USOTC
PSRU
Valiant Eagle (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
RDAR
Raadr (PK)
USOTC
TKMO
Tekumo (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
PPCB
Propanc Biopharma (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
XCRT
Xcelerate (QB)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
IQST
iQSTEL (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved